Patient access: How Novartis, Eli Lilly, and other Big Pharmas measure up

Getting life-saving medications into the hands of people around the world remains a top priority for pharma companies. But whether those efforts are working is up for debate.

A new report from the Access to Medicine Foundation, a nonprofit that tracks how well the industry develops and provides medicines, has shed more light on Big Pharma’s global access initiatives.